ABIOMED INC. DL-,01
stock DE:AIO (FRANKFURT)

Alternative ID: US0036541003

Watch List

Exchange: FRANKFURT
Sector: Healthcare
Industry: Medical Devices
Market Cap: Large (16.45B)
Data in EUR

EPS: 4.10
Current PE: 4.19
BVPS: 28.19
Price/BVPS: 0.63
Dividend: 0.00 / 0.0%

Hist Grade: B (71.07)
YOY Grade: B (67.44)
Debt/FCF: 0.04
ROIC: 7.1%
PEG: 0.42
PEGY: 0.42

Value Price: 287.46
MOS Price: 143.73
MOS %: 1,521.3%
Graham Number: 50.98
Graham MOS %: 187.6%
IRT: 3.05

Market Price

17.73

0.50 2.9%

as of Jun 06 '23

52 Week Range:

15.88 382.40

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: FRANKFURT
Sector: Healthcare
Industry: Medical Devices
Market Cap: Large (16.45B)
Inst. Ownership: 95.20%
Insider Ownership: 2.01%
Full Time Employees: 2003

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Mar '12	Mar '13	Mar '14	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22
Equity (BVPS)	2.25	2.76	2.92	4.37	7.16	8.94	11.58	16.81	21.09	23.77	28.19
growth rate		22.7%	5.8%	49.7%	63.8%	24.9%	29.5%	45.2%	25.5%	12.7%	18.6%
Earnings BIT			8.36	29.18	66.16	91.73	158.47	223.90	248.64	232.86	256.71
growth rate				248.9%	126.8%	38.7%	72.8%	41.3%	11.1%	-6.4%	10.2%
Avg.PE					100.71	104.44	134.47	66.44	66.44	75.56	92.02
growth rate						3.7%	28.8%	-50.6%	0.0%	13.7%	21.8%
ROA	1.05	9.27	3.92	41.81	10.01	10.70	16.78	28.14	17.88	16.64	8.62
growth rate		782.9%	-57.7%	966.6%	-76.1%	6.9%	56.8%	67.7%	-36.5%	-6.9%	-48.2%
ROE	1.29	11.40	4.81	49.44	11.55	12.70	19.65	31.85	20.28	18.83	9.64
growth rate		783.7%	-57.8%	927.9%	-76.6%	10.0%	54.7%	62.1%	-36.3%	-7.2%	-48.8%
ROIC	1.29	11.40	4.81	49.44	11.55	12.21	19.39	31.85	20.28	18.83	7.12
growth rate		783.7%	-57.8%	927.9%	-76.6%	5.7%	58.8%	64.3%	-36.3%	-7.2%	-62.2%
Cur. Ratio	4.93	4.31	3.88	5.60	6.20	4.70	5.84	6.39	4.82	6.11	7.05
growth rate		-12.6%	-10.0%	44.3%	10.7%	-24.2%	24.3%	9.4%	-24.6%	26.8%	15.4%
Quick Ratio	4.36	3.68	3.32	4.17	5.48	4.08	5.10	5.50	4.00	5.28	6.13
growth rate		-15.6%	-9.8%	25.6%	31.4%	-25.6%	25.0%	7.8%	-27.3%	32.0%	16.1%
Leverage	1.22	1.24	1.22	1.16	1.15	1.22	1.14	1.13	1.14	1.12	1.11
growth rate		1.6%	-1.6%	-4.9%	-0.9%	6.1%	-6.6%	-0.9%	0.9%	-1.8%	-0.9%
Balance Sheet	Mar '12	Mar '13	Mar '14	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22
Acct.Receivable			24.36	31.83	42.82	54.06	70.01	90.81	84.65	97.18	90.61
growth rate				30.7%	34.5%	26.2%	29.5%	29.7%	-6.8%	14.8%	-6.8%
Acct.Payable			7.75	10.39	9.38	20.62	23.57	32.19	32.77	34.84	35.35
growth rate				34.1%	-9.7%	119.8%	14.3%	36.6%	1.8%	6.3%	1.5%
Cur.Assets			117.97	185.04	288.39	326.96	494.27	677.20	635.86	787.97	976.47
growth rate				56.9%	55.9%	13.4%	51.2%	37.0%	-6.1%	23.9%	23.9%
Total Assets			205.41	338.37	423.93	550.41	786.38	1,054.35	1,216.46	1,494.36	1,673.39
growth rate				64.7%	25.3%	29.8%	42.9%	34.1%	15.4%	22.8%	12.0%
Cash			20.92	22.40	48.23	39.04	42.98	121.02	192.34	232.71	132.82
growth rate				7.1%	115.3%	-19.1%	10.1%	181.6%	58.9%	21.0%	-42.9%
Inventory			13.95	16.77	26.74	34.93	50.20	80.94	90.09	81.06	93.98
growth rate				20.3%	59.4%	30.6%	43.7%	61.2%	11.3%	-10.0%	15.9%
Cur.Liabilities			30.41	39.32	46.54	69.62	84.68	106.00	131.89	128.97	138.46
growth rate				29.3%	18.4%	49.6%	21.6%	25.2%	24.4%	-2.2%	7.4%
Liabilities			37.05	46.81	55.16	98.34	96.85	117.46	151.00	164.68	170.07
growth rate				26.3%	17.8%	78.3%	-1.5%	21.3%	28.6%	9.1%	3.3%
LT Debt						15.54				4.30	9.32
growth rate										-27.5%	116.8%
Equity			168.35	291.56	368.78	452.07	689.52	936.89	1,065.47	1,329.68	1,503.33
growth rate				73.2%	26.5%	22.6%	52.5%	35.9%	13.7%	24.8%	13.1%
Common Shares	40.00	41.00	42.00	43.00	45.00	45.00	46.00	0.45	0.45	0.45	0.46
growth rate		2.5%	2.4%	2.4%	4.7%	0.0%	2.2%	-99.0%	0.0%	0.4%	0.4%
Cash Flow Statement	Mar '12	Mar '13	Mar '14	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22
Capital Expenditures			2.76	5.19	15.62	50.42	55.86	44.00	44.01	53.38	35.76
growth rate				87.9%	201.2%	222.7%	10.8%	-21.2%	0.0%	21.3%	-33.0%
Cash From OA			23.47	43.29	76.80	115.12	192.55	252.20	314.92	274.58	285.39
growth rate				84.5%	77.4%	49.9%	67.3%	31.0%	24.9%	-12.8%	3.9%
FCF per Share	-0.08	0.40	0.32	0.70	1.22	1.44	1.84	3.69	5.06	4.43	4.81
growth rate		100.0%	-20.0%	118.8%	74.3%	18.0%	27.8%	100.5%	37.1%	-12.5%	8.6%
Sale Purchase of Stock			10.06	11.72	10.91	12.38	11.70
growth rate				16.6%	-7.0%	13.5%	-5.5%
FCF	2.00	24.00	21.00	38.00	61.00	65.00	137.00	208.00	271.00	221.00	250.00
growth rate		1,100.0%	-12.5%	81.0%	60.5%	6.6%	110.8%	51.8%	30.3%	-18.5%	13.1%
Income Statement	Mar '12	Mar '13	Mar '14	Mar '15	Mar '16	Mar '17	Mar '18	Mar '19	Mar '20	Mar '21	Mar '22
Sales			183.64	230.31	329.54	445.30	593.75	769.43	840.88	847.52	1,031.75
growth rate				25.4%	43.1%	35.1%	33.3%	29.6%	9.3%	0.8%	21.7%
Op.Income			8.36	29.18	66.16	91.73	158.47	223.90	248.64	232.86	256.71
growth rate				248.9%	126.8%	38.7%	72.8%	41.3%	11.1%	-6.4%	10.2%
IBT			8.53	28.77	65.84	91.34	160.44	263.36	256.83	288.22	190.56
growth rate				237.2%	128.9%	38.7%	75.6%	64.2%	-2.5%	12.2%	-33.9%
Net Income			7.35	113.69	38.15	52.12	112.17	259.02	203.01	225.53	136.51
growth rate				1,446.6%	-66.5%	36.6%	115.2%	130.9%	-21.6%	11.1%	-39.5%
EPS	0.04	0.37	0.18	2.65	0.85	1.17	2.45	5.61	4.43	4.94	2.98
growth rate		825.0%	-51.4%	1,372.2%	-67.9%	37.7%	109.4%	129.0%	-21.0%	11.5%	-39.7%
Gross Profit			146.32	190.37	279.12	374.68	495.17	639.87	689.58	685.62	843.60
growth rate				30.1%	46.6%	34.2%	32.2%	29.2%	7.8%	-0.6%	23.0%
R&D			30.71	35.46	48.71	64.80	73.96	94.42	99.33	119.47	163.40
growth rate				15.5%	37.3%	33.0%	14.1%	27.7%	5.2%	20.3%	36.8%

Quarterly Statements

Item Name	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22
Earnings BIT	60.44	65.06	65.00	62.69	57.99
growth rate		7.7%	-0.1%	-3.6%	-7.5%
Balance Sheet	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22
Acct.Receivable	89.57	88.95	90.61	91.10	94.48
growth rate		-0.7%	1.9%	0.6%	3.7%
Acct.Payable	27.62	32.07	35.35	34.80	35.07
growth rate		16.1%	10.2%	-1.6%	0.8%
Cur.Assets	871.49	885.01	976.47	1,060.36	1,062.80
growth rate		1.6%	10.3%	8.6%	0.2%
Total Assets	1,530.03	1,592.88	1,673.39	1,703.64	1,696.54
growth rate		4.1%	5.1%	1.8%	-0.4%
Cash	241.88	144.26	132.82	180.49	182.34
growth rate		-40.4%	-7.9%	35.9%	1.0%
Inventory	85.99	90.20	93.98	95.37	102.24
growth rate		4.9%	4.2%	1.5%	7.2%
Cur.Liabilities	114.02	126.80	138.46	140.76	134.06
growth rate		11.2%	9.2%	1.7%	-4.8%
Liabilities	145.47	159.94	170.07	167.44	156.76
growth rate		10.0%	6.3%	-1.5%	-6.4%
LT Debt	2.77	2.13	9.32
growth rate		-23.0%	337.3%
Equity	1,384.56	1,432.94	1,503.33	1,536.20	1,539.79
growth rate		3.5%	4.9%	2.2%	0.2%
Common Shares	0.46	0.46	0.46	0.46	0.45
growth rate		0.0%	0.0%	0.2%	-0.9%
Cash Flow Statement	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22
Capital Expenditures	7.22	6.48	14.89	6.78	5.61
growth rate		-10.3%	129.9%	-54.5%	-17.3%
Cash From OA	60.57	90.49	78.97	68.10	13.42
growth rate		49.4%	-12.7%	-13.8%	-80.3%
Sale Purchase of Stock
growth rate
FCF	53.35	84.01	64.08	61.32	7.81
growth rate		57.5%	-23.7%	-4.3%	-87.3%
Income Statement	Sep '21	Dec '21	Mar '22	Jun '22	Sep '22
Sales	248.14	261.18	269.85	277.15	265.92
growth rate		5.3%	3.3%	2.7%	-4.1%
Op.Income	60.44	65.06	65.00	62.69	57.99
growth rate		7.7%	-0.1%	-3.6%	-7.5%
IBT	67.27	57.88	74.76	69.82	138.70
growth rate		-14.0%	29.2%	-6.6%	98.7%
Net Income	56.95	45.75	60.33	54.55	106.13
growth rate		-19.7%	31.9%	-9.6%	94.6%
Gross Profit	204.26	213.55	218.39	224.52	217.04
growth rate		4.6%	2.3%	2.8%	-3.3%
R&D	41.04	40.87	43.79	43.84	42.09
growth rate		-0.4%	7.1%	0.1%	-4.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (71.07)

YOY Growth Grade:

B (67.44)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 0.0%
Beta: 1.31
Beta of 1.3143 suggests that the asset is more volatile than the rest of the market.
PE: 4.19
EY: 23.9%
PEG: 0.42
PEG Ratio of 0.42 suggests that stock is underpriced.
PEGY: 0.42
PEGY Ratio of 0.42 suggests that stock is underpriced.
Price/BVPS: 0.63
Price to BVPS Ratio of 0.63 suggests that stock is undervalued.

Profitability Ratios

ROE: 9.6%
Return on Equity (ROE) of 9.6% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.
ROS: 24.9%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: 11.4%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 12.7%
Return on Investment (ROI) of 12.7% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.
ROIC: 7.1%
Return on Invested Capital (ROIC) of 7.1% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.

Liquidity Ratios

Current Ratio: 7.05
Current Ratio of 7.05 suggests that money that could be working for the business is tied up in government securities, cash savings or other safe funds.
Quick Ratio: 1.61
Quick Ratio of 1.61 suggests that a company is doing well.
Cash Turnover: 1.23
Turnover Of Cash Ratio of 1.23 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.
Equity Ratio: 89.8%
Equity Ratio of 89.8% suggests that a large percent of the company's assets financed by shareholder equity, which is good.
Debt/Equity: 11.3%
Debt to Equity Ratio of 11.3% suggests that a company is doing well.
Debt/FCF: 0.04
Debt/FCF of 0.04 suggests that a company is doing well and can pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 32.05
Average Collection Period of 32.05 days suggests that a company is doing well.
Inventory Turnover: 2.00
Inventory Turnover Ratio of 2.00 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or it could indicate poor liquidity and possible overstocking of items.
Cash Flow Ratio: 5.22
Cash Flow Ratio of 5.22 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.
Profit Margin: 13.2%

Value Price

PE and EPS

	Historical	Current	Forward
PE	87.14	4.33	66.87
EPS / Growth	60.4%	4.10	10.0%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 22.7%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	10.0%	16.4%	16.4%
Future PE	20.06	62.26	62.26
Future EPS	10.66	18.68	18.68
Value Price MOS %	52.85 198.1%	287.46 1,521.3%	287.46 1,521.3%
MOS Price	26.42	143.73	143.73
IRT	3.47	3.13	3.13

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 50.98
Graham MOS: 187.6%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.